James Ballenger to Monoamine Oxidase Inhibitors
This is a "connection" page, showing publications James Ballenger has written about Monoamine Oxidase Inhibitors.
Connection Strength
0.309
-
Recent developments in the psychopharmacology of anxiety disorders. J Consult Clin Psychol. 1996 Aug; 64(4):660-8.
Score: 0.131
-
Pharmacotherapy of the panic disorders. J Clin Psychiatry. 1986 Jun; 47 Suppl:27-32.
Score: 0.065
-
Consensus statement on panic disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry. 1998; 59 Suppl 8:47-54.
Score: 0.036
-
Long-term pharmacologic treatment of panic disorder. J Clin Psychiatry. 1991 Feb; 52 Suppl:18-23; discussion 24-5.
Score: 0.022
-
Decisions for the clinician in the treatment of panic disorder: when to treat, which treatment to use, and how long to treat. J Clin Psychiatry. 1991 Feb; 52 Suppl:26-31; discussion 32.
Score: 0.022
-
Antidepressants in panic disorder and agoraphobia. J Affect Disord. 1987 Sep-Oct; 13(2):153-68.
Score: 0.018
-
Psychopharmacology of the anxiety disorders. Psychiatr Clin North Am. 1984 Dec; 7(4):757-71.
Score: 0.015